| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.02B | +4.1% |
| Cost of Revenue | $704.6M | +3.7% |
| Gross Profit | $313.1M | +5.0% |
| R&D Expense | $29.2M | +19.7% |
| SG&A Expense | $259.8M | +14.7% |
| Operating Income | $53.3M | -25.8% |
| Pre-tax Income | $10.9M | -79.8% |
| Income Tax | $8.5M | -60.4% |
| Net Income | $2.4M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.6M | +71.1% |
| Short-term Investments | $44.0M | +10.0% |
| Accounts Receivable | $169.5M | +3.7% |
| Inventory | $265.9M | -4.2% |
| Current Assets | $601.0M | +2.6% |
| Total Assets | $982.2M | +1.1% |
| Current Liabilities | $204.1M | +16.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $87.6M | +558.1% |
| Investing Cash Flow | -$48.2M | +34.9% |
| Financing Cash Flow | -$6.8M | -125.1% |
| -92.6% |
| EPS (Basic) | $0.06 | -92.6% |
| EPS (Diluted) | $0.06 | -92.6% |
| Long-term Debt |
| $312.1M |
| -6.5% |
| Total Liabilities | $725.5M | +5.3% |
| Stockholders' Equity | $256.6M | -9.2% |